| Neuropace is a medical device company focused on transforming the lives of people with epilepsy. Co.'s RNS System is a brain-responsive neuromodulation system that delivers personalized, real-time treatment at the seizure source. By monitoring the brain's electrical activity, recognizing patient-specific abnormal electrical patterns, and responding in real time with imperceptible electrical pulses to prevent seizures, Co.'s RNS System is programmed by clinicians to deliver the amount of therapy when and where it is needed and provides exceptional clinical outcomes. Co.'s RNS System records brain activity data and allows clinicians to monitor patients not only in person, but also remotely. We show 11 historical shares outstanding datapoints in our NPCE shares outstanding history coverage, used to compute NPCE market cap on those dates.|
Understanding the changing numbers of shares outstanding, the changing
share price, and the resulting changing NPCE market cap history over the course of time is important for investors
interested in comparing NPCE's market cap history versus its peers.
Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at
a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies,
and then calculating their respective market caps. Comparing the share price of NPCE versus a peer is one thing; comparing
NPCE market cap versus a peer is a completely different story.
Furthermore, via fluctuation both in per-share price and in the number of shares outstanding (via issuance of new shares over time, the repurchase of existing shares),
the market cap for a company like NPCE can fluctuate over the course of history.
With this page we aim to empower investors researching NPCE by allowing them to research the NPCE market cap history.